2 Safe-and-Steady Stocks with Solid Fundamentals and 1 to Think Twice About
2 Reasons to Like AMPH and 1 to Stay Skeptical
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating...
Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Avanos Medical, Inc. AVNS is a medical technology company focusing on delivering medical device solutions. The Zacks Consensus...
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...
Amphastar Pharmaceuticals posted modest earnings growth but fell short of market expectations in its latest quarterly results.